#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Malignant glioma Vulval cancer recurrent Hypertriglyceridaemia Encephalopathy neonatal Heart disease congenital Thrombotic microangiopathy Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Anaplastic thyroid cancer Infective uveitis Homocystinuria Bladder cancer Fms-like tyrosine kinase 3 positive Alagille syndrome Small cell lung cancer extensive stage More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Life with Disease Primary biliary cholangitis – Diagnostics Stevens-Johnson syndrome – Treatment Encephalitis autoimmune – Life with Disease Behcet’s syndrome – Diagnostics Breast angiosarcoma – Life with Disease Tuberous sclerosis complex – Basic Information Biotinidase deficiency – Treatment Hairy cell leukaemia recurrent – Basic Information Niemann-Pick disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Radium Ra 223 Dichloride Lixisenatide Human Coagulation Factor Viii Ferric Derisomaltose Theophylline Vixarelimab Glucose Monohydrate Pirfenidone Tiapride Sodium Glycerophosphate Odm-212 SARACATINIB Fenfluramine Hydrochloride Thiamine Lysine Aspirin VX-407 Eribulin Mesylate R-Azasetron Besilate Lufepirsen ALLERGEN EXTRACTS More therapies…

    Learn about Your Condition

    Tricuspid valve disease Vulvar dysplasia Optic atrophy Craniopharyngioma Metabolic surgery Double hit lymphoma Vulvovaginal pain Oxygen saturation Cluster headache Cardiac disorder Soft tissue sarcoma Appendicitis Becker's muscular dystrophy Gender dysphoria Corneal graft failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    • Nephrotic syndrome
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Atacicept
    Belgium France Germany Italy Poland Spain

  • Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Azathioprine
    • Methylprednisolone Hydrogen Succinate
    • Sirolimus
    France

  • Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

    Recruiting

    2 1
    Bulgaria Czechia France Hungary Poland Spain

  • Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Arginine Hydrochloride
    • Dimeticone
    • Lysine Hydrochloride
    France Germany Hungary Italy The Netherlands Poland +1

  • Study of intramuscular methylprednisolone acetate to treat pain in patients with hand osteoarthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Sodium Chloride
    • Methylprednisolone Acetate
    The Netherlands
Previous Page
1 … 156 157 158 159 160 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!